Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection

Susceptibility to SARS-CoV-2 breakthrough infection in those with hybrid immunity is strongly associated with low levels of pre-existing antibody, but the diversity of immune markers associated with protection implies that additional benefits may be conferred by multi-pronged immunity.

A. Singanayagam, H. Wagstaffe, L. J. Slater et al. · 0 citations
#protein folding Open access Aug 2026

Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays

Three commonly used types of neutralization assay were compared and strong correlations and significant differences in measured neutralization between the different assays were found, highlighting areas for more precise and harmonized terminology and particular assay elements that must be considered in efforts to harmonize neutralization assays.

E. Stadler, F. Mordant, Matthew J. Gartner et al. · 0 citations